Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu-na Wang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|May 15, 2015
[A high sensitivity micro-ring humidity sensor based on U-shaped waveguide coupled single micro-ring structure]Zhi-quan Li, Lu-na Wang, Xin Li, et al.
Journal of Thrombosis and Thrombolysis|October 18, 2017
Cerebral venous sinus thrombosis complicated by seizures: a retrospective analysis of 69 casesDu-Juan Sha, Jian Qian, Shuang-Shuang Gu, et al.
Dalton Transactions (Cambridge, England : 2003)|October 24, 2022
Crystal structure, assembly process, and single-molecule magnet behavior of a triangular prismatic {Co<sub>9</sub>} clusterYe Tao, Lu-Na Wang, Hai-Ye Li, et al.
Quantitative Imaging in Medicine and Surgery|October 21, 2024
Using CT features of cystic airspace to predict lung adenocarcinoma invasivenessYu Zhang, Bo-Wen Ding, Lu-Na Wang, et al.
Liver Cancer|April 21, 2025
Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus ImmunotherapyBin Xu, Lu-Na Wang, Zi-Yi Wang, et al.
International Immunopharmacology|March 16, 2024
Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapiesZi-Yi Wang, Bin Xu, Lu-Na Wang, et al.
Biomarker Research|January 13, 2025
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapyTian He, Bin Xu, Lu-Na Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2025
CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy ResistanceTian He, Zi-Yi Wang, Bin Xu, et al.
Liver Cancer|March 12, 2026
Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular CarcinomaTian He, Bin Xu, Zi-Yue Yang, et al.
Hepatology (Baltimore, Md.)|February 26, 2026
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomyShi-Qi Zhou, Lu-Na Wang, Li-Fang Wu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|May 15, 2015
[A high sensitivity micro-ring humidity sensor based on U-shaped waveguide coupled single micro-ring structure]Zhi-quan Li, Lu-na Wang, Xin Li, et al.
Journal of Thrombosis and Thrombolysis|October 18, 2017
Cerebral venous sinus thrombosis complicated by seizures: a retrospective analysis of 69 casesDu-Juan Sha, Jian Qian, Shuang-Shuang Gu, et al.
Dalton Transactions (Cambridge, England : 2003)|October 24, 2022
Crystal structure, assembly process, and single-molecule magnet behavior of a triangular prismatic {Co<sub>9</sub>} clusterYe Tao, Lu-Na Wang, Hai-Ye Li, et al.
Quantitative Imaging in Medicine and Surgery|October 21, 2024
Using CT features of cystic airspace to predict lung adenocarcinoma invasivenessYu Zhang, Bo-Wen Ding, Lu-Na Wang, et al.
Liver Cancer|April 21, 2025
Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus ImmunotherapyBin Xu, Lu-Na Wang, Zi-Yi Wang, et al.
International Immunopharmacology|March 16, 2024
Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapiesZi-Yi Wang, Bin Xu, Lu-Na Wang, et al.
Biomarker Research|January 13, 2025
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapyTian He, Bin Xu, Lu-Na Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2025
CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy ResistanceTian He, Zi-Yi Wang, Bin Xu, et al.
Liver Cancer|March 12, 2026
Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular CarcinomaTian He, Bin Xu, Zi-Yue Yang, et al.
Hepatology (Baltimore, Md.)|February 26, 2026
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomyShi-Qi Zhou, Lu-Na Wang, Li-Fang Wu, et al.
Pageof 1